References
- Bodaghi B, Cassoux N, Wechsler B, et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore). 2001;80(4):263–270. doi:10.1097/00005792-200107000-00005.
- Nussenblatt RB. The natural history of uveitis. Int Ophthalmol. 1990;14(5–6):303–308. doi:10.1007/BF00163549.
- Bertrand P-J, Jamilloux Y, Ecochard R, et al. Uveitis: autoimmunity … and beyond. Autoimmun Rev. 2019;18(9):102351. doi:10.1016/j.autrev.2019.102351.
- Selmi C. Diagnosis and classification of autoimmune uveitis. Autoimmun Rev. 2014;13(4–5):591–594. doi:10.1016/j.autrev.2014.01.006.
- Rothova A, Buitenhuis HJ, Meenken C, et al. Uveitis and systemic disease. Br J Ophthalmol. 1992;76(3):137–141. doi:10.1136/bjo.76.3.137.
- Smit RL, Baarsma GS, De Vries J. Classification of 750 consecutive uveitis patients in the Rotterdam Eye Hospital. Int Ophthalmol. 1993;17(2):71–76. doi:10.1007/BF00942778.
- Tran VT, Auer C, Guex-Crosier Y, Pittet N, Herbort CP. Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol. 1994;18(5):293–298. doi:10.1007/BF00917833.
- Lee CS, Randhawa S, Lee AY, Lam DL, Van Gelder RN. Patterns of laboratory testing utilization among uveitis specialists. Am J Ophthalmol. 2016;170:161–167. doi:10.1016/j.ajo.2016.08.004.
- Hadjadj J, Dechartres A, Chapron T, et al. Relevance of diagnostic investigations in patients with uveitis: retrospective cohort study on 300 patients. Autoimmun Rev. 2017;16(5):504–511. doi:10.1016/j.autrev.2017.03.006.
- Pelegrín L, Hernández-Rodríguez J, Espinosa G, et al. Characterization of isolated retinal vasculitis. Analysis of a cohort from a single center and literature review. Autoimmun Rev. 2017;16(3):237–243. doi:10.1016/j.autrev.2017.01.006.
- De Parisot A, Kodjikian L, Errera M-H. et al. Randomized controlled trial evaluating a standardized strategy for uveitis etiologic diagnosis (ULISSE). Am J Ophthalmol. 2017;178:176–185. doi:10.1016/j.ajo.2017.03.029.
- Abad S, Sève P, Dhote R, Brézin A-P. [Guidelines for the management of uveitis in internal medicine]. Rev Med Interne. 2009;30(6):492–500. doi:10.1016/j.revmed.2008.08.011.
- Grumet P, Kodjikian L, De Parisot A, et al. Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis: clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis). Autoimmun Rev. 2018;17(4):331–343. doi:10.1016/j.autrev.2017.10.018.
- Gil H, Fery-Blanco C, Schwartz C, et al. [Contribution of cerebral magnetic resonance imaging to etiological investigation of uveitis]. Rev Med Interne. 2014;35(12):790–793. doi:10.1016/j.revmed.2014.04.008.
- Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
- Cunningham ET, Pavesio CE, Goldstein DA, Forooghian F, Zierhut M. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2017;25(3):299–301. doi:10.1080/09273948.2017.1334469.
- Petrushkin H, Kidd D, Pavesio C. Intermediate uveitis and multiple sclerosis: to scan or not to scan. Br J Ophthalmol. 2015;99(12):1591–1593. doi:10.1136/bjophthalmol-2015-307269.
- Yamout B, Al Khawajah M. Radiologically isolated syndrome and multiple sclerosis. Mult Scler Relat Disord. 2017;17:234–237. doi:10.1016/j.msard.2017.08.016.
- Randomized, double-blinded study of treatment: Teriflunomide, in radiologically isolated syndrome - full text view - ClinicalTrials.gov. Accessed December 17, 2019. https://clinicaltrials.gov/ct2/show/NCT03122652
- Assessment of Tecfidera® in radiologically isolated syndrome (RIS) - full text view - ClinicalTrials.gov. Accessed December 17, 2019. https://clinicaltrials.gov/ct2/show/NCT02739542
- Sève P, Bodaghi B, Trad S, et al. [Uveitis: diagnostic work-up. Recommendations from an expert committee]. Rev Med Interne. 2018;39(9):676–686. doi:10.1016/j.revmed.2017.09.015.
- Winkelmann A, Patejdl R, Wagner S, Benecke R, Zettl UK. Cerebral MRI lesions and anti-tumor necrosis factor-alpha therapy. J Neurol. 2008;255(Suppl 6):109–114. doi:10.1007/s00415-008-6020-z.
- Wakefield D, McCluskey P, Wildner G, et al. Inflammatory eye disease: pre-treatment assessment of patients prior to commencing immunosuppressive and biologic therapy: recommendations from an expert committee. Autoimmun Rev. 2017;16(3):213–222. doi:10.1016/j.autrev.2017.01.003.
- Olsen TG, Frederiksen J. The association between multiple sclerosis and uveitis. Surv Ophthalmol. 2017;62(1):89–95. doi:10.1016/j.survophthal.2016.07.002.
- Kimura K, Usui Y, Goto H. Japanese intraocular lymphoma study group. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol. 2012;56(4):383–389. doi:10.1007/s10384-012-0150-7.
- Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302. doi:10.1002/ana.22366.
- Pulido JS, Johnston PB, Nowakowski GS, Castellino A, Raja H. The diagnosis and treatment of primary vitreoretinal lymphoma: a review. Int J Retin Vitr. 2018;4(1):18. doi:10.1186/s40942-018-0120-4.
- Bajwa A, Lee CS, Patrie J, Xin W, Reddy AK. Clinical and visual outcomes of patients with uveitis in the mid-Atlantic United States. Clin Ophthalmol. 2015;9:1655–1664. doi:10.2147/OPTH.S88647.
- Luca C, Raffaella A, Sylvia M, et al. Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases. Int Ophthalmol. 2018;38(1):133–142. doi:10.1007/s10792-016-0434-x.
- Jakob E, Reuland MS, Mackensen F, et al. Uveitis subtypes in a german interdisciplinary uveitis center–analysis of 1916 patients. J Rheumatol. 2009;36(1):127–136. doi:10.3899/jrheum.080102.
- Tsirouki T, Dastiridou A, Symeonidis C, et al. A Focus on the Epidemiology of Uveitis. Ocul Immunol Inflamm. 2018;26(1):2–16. doi:10.1080/09273948.2016.1196713.